Featuring slide presentations and related discussion from Drs
Petros Grivas, Daniel P Petrylak and Arlene Siefker-Radtke,
including the following topics:
Key Data Supporting the Use of Antibody-Drug Conjugates in
Bladder Cancer — Daniel P Petrylak, MD (0:00)
Approved and Investigational FGFR-Targeted Therapies in
Advanced Urothelial Bladder Cancer — Arlene Siefker-Radtke, MD
(33:01)
Current and Future Role of Immune Checkpoint Inhibitors in
Urothelial Bladder Cancer — Petros Grivas, MD, PhD (1:21:15)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.